Cargando…
Complement Inhibitors for Advanced Dry Age-Related Macular Degeneration (Geographic Atrophy): Some Light at the End of the Tunnel?
Geographic atrophy (GA) affects around 5 million individuals worldwide. Genome-wide, histopathologic, in vitro and animal studies have implicated the activation of the complement system and chronic local inflammation in the pathogenesis of GA. Recently, clinical trials have demonstrated that an intr...
Autores principales: | Cruz-Pimentel, Miguel, Wu, Lihteh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10420150/ https://www.ncbi.nlm.nih.gov/pubmed/37568533 http://dx.doi.org/10.3390/jcm12155131 |
Ejemplares similares
-
Choriocapillaris changes in dry age-related macular degeneration and geographic atrophy: a review
por: Arya, Malvika, et al.
Publicado: (2018) -
A Review of Completed and Ongoing Complement Inhibitor Trials for Geographic Atrophy Secondary to Age-Related Macular Degeneration
por: Halawa, Omar A., et al.
Publicado: (2021) -
THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET
por: Boyer, David S., et al.
Publicado: (2017) -
Local Complement Inhibition for Geographic Atrophy in Age-Related Macular Degeneration: Prospects, Challenges, and Unanswered Questions
por: Keenan, Tiarnan D.L.
Publicado: (2021) -
C1q and the classical complement cascade in geographic atrophy secondary to age-related macular degeneration
por: Yednock, Ted, et al.
Publicado: (2022)